The Office of Health Economics this week launched the 'OHE Guide to UK Health and Health Care Statistics'.
We have argued for many years that supporting patient access to innovation will in turn support the pharmaceutical industry and make the UK a more attractive place for our industry to do business.
Hosted by Andrew Miller MP, the ABPI parliamentary event discussion on innovation and commercial success also marked the launch of the spring issue of 'Science in Parliament', which examines current issues and developments in the bio-pharmaceutical sector.
Today, March 7th sees the launch of the PRIME initiative by the European Medicines Agency. This scheme aims to strengthen support to medicines that have the potential to benefit patients who presently have no treatment options, or that may offer a major therapeutic advantage over existing treatments...
Recent debate by some healthcare policy makers about how the NHS should spend money for patients reaching the end of their life has argued it might be better to direct resources to improving the quality of life of people close to death rather than spending money on medicines to extend their life for...
New ABPI Chief Executive Stephen Whitehead gave his first speech last night at the ABPI Parliamentary Conference, in Portcullis House, hosted by Health Select Committee chair Stephen Dorrell MP.
The ABPI held a lively conference of debate and discussion at its November conference which took place last week in London at the home of British science, the Royal Society.
In its Plan for Growth Review, the Government pledged to speed-up the regulatory process around clinical trials in the UK. This was welcomed by the Association of the British Pharmaceutical Industry and its members who have long called for action.
Merry Christmas and a Happy New Year from the ABPI. Thank you for your support this year and we look forward to working with you in 2014.
In this film, ABPI President and Co-Chair of the Ethical Standards in Health and Life Sciences Group (ESHLSG) Simon Jose talks about the new set of guidelines to promote positive collaboration between health organisations and the pharmaceutical industry in the UK.